Zanamivir
1 NDC across 1 manufacturer|0 Generic,1 Brand
Zanamivir is used to treat human influenza, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 26, 1999. In 2024, Medicare Part D spent $13K on Zanamivir across 194 claims for 114 beneficiaries.
Zanamivir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $2.83 to $2.83 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$2.83 – $2.83
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ZANAMIVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RELENZA 5 MG DISKHALER | $2.8319 per EA | — |
Frequently Asked Questions
What is Zanamivir used to treat?
Zanamivir is used to treat human influenza, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Zanamivir?
In 2024, Medicare Part D spent $13K on Zanamivir across 194 claims for 114 beneficiaries.
How many Zanamivir products are on the market?
The Zanamivir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Zanamivir?
NADAC reference prices for Zanamivir range from $2.8319 to $2.8319 per EA.
Which manufacturers make Zanamivir?
1 manufacturer lists Zanamivir in NADAC. Ranked by number of NDCs, the largest are GlaxoSmithKline LLC (1).